Inhibiting thyroid activation in aged human explants prevents mechanical induced detrimental signalling by mitigating metabolic processes. (5th April 2022)

• Record Type: Journal Article
• Authors: Houtman, Evelyn; Tuerlings, Margo; Suchiman, H Eka D; Lakenberg, Nico; Cornelis, Frederique M F; Mei, Hailiang; Broekhuis, Demiën; Nelissen, Rob G H H; Coutinho de Almeida, Rodrigo; Ramos, Yolande F M; Lories, Rik J; Cruz, Luis J; Meulenbelt, Ingrid
• Is Part Of: Rheumatology. Volume 62:Number 1(2023)
• Page Start: 457
• Page End: 466
• Publication Date: 2022-04-05
• Subjects: OA -- DIO2 -- chondrocytes -- cartilage -- thyroid signalling -- iopanoic acid -- mechanical stress; Rheumatism -- Periodicals; Rheumatology -- Periodicals; 616.723005
• DOI: 10.1093/rheumatology/keac202
• Languages: English
• ISSNs: 1462-0324

Abstract

Abstract: Objectives: To investigate whether the deiodinase inhibitor iopanoic acid (IOP) has chondroprotective properties, a mechanical stress induced model of human aged explants was used to test both repeated dosing and slow release of IOP. Methods: Human osteochondral explants subjected to injurious mechanical stress (65%MS) were treated with IOP or IOP encapsulated in poly lactic-co-glycolic acid–polyethylene glycol nanoparticles (NP-IOP). Changes to cartilage integrity and signalling were determined by Mankin scoring of histology, sulphated glycosaminoglycan (sGAG) release and expression levels of catabolic, anabolic and hypertrophic markers. Subsequently, on a subgroup of samples, RNA sequencing was performed on 65%MS ( n = 14) and 65%MS+IOP ( n = 7) treated cartilage to identify IOP's mode of action. Results: Damage from injurious mechanical stress was confirmed by increased cartilage surface damage in the Mankin score, increased sGAG release, and consistent upregulation of catabolic markers and downregulation of anabolic markers. IOP and, though less effective, NP-IOP treatment, reduced MMP13 and increased COL2A1 expression. In line with this, IOP and NP-IOP reduced cartilage surface damage induced by 65%MS, while only IOP reduced sGAG release from explants subjected to 65%MS. Lastly, differential expression analysis identified 12 genes in IOP's mode of action to be mainly involved in reducing metabolic processes ( INSIG1, DHCR7, FADS1 and ACAT2 ) and proliferation and differentiation ( CTGF, BMP5 and FOXM1 ). Conclusion: Treatment with the deiodinase inhibitor IOP reduced detrimental changes of injurious mechanical stress. In addition, we identified that its mode of action was likely on metabolic processes, cell proliferation and differentiation.